Jiangsu Hengrui Eyes $2 Billion Hong Kong IPO
Jiangsu Hengrui Pharmaceuticals Co. plans a Hong Kong listing to potentially raise $2 billion. Stay updated on this major pharmaceutical IPO.
Topic
Jiangsu Hengrui
A collection of 1 issue